Evaluation of automatic antimicrobial susceptibility testing with the MS-2 system. 1984

M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice

We present the results of sensitivity of 191 Gram-negative bacteria towards the following antibiotics: aminoglycosides (amikacin, gentamicin, tobramycin, netilmicin), cephalosporines (moxalactam, cefotaxime, ceftazidime) and piperacilline obtained by agar diffusion method (Kirby-Bauer) versus automatic system MS 2 Abbott. Essential accord expressed in percentage is for amikacin 96%, for gentamicin 93%, for moxalactam 91%, for tobramycin 95%, for cefotaxime 92%, for piperacilline 89%, for netilmicin 90%, for ceftazidime 92. Full accord gives more discrepant results especially for cephalosporins. For aminoglycosides no significative differences were observed between the two methods. For cephalosporins the incidence of discordance was a little more high. A better sensitivity was obtained by Kirby-Bauer method versus automatic system, which can be considered a therapeutical tool as it furnishes rapidly (4 hours) MIC values, useful to establish antibiotic doses.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010878 Piperacillin Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics. AB-Piperacillin,Cl-227193,Pipcil,Pipera-Hameln,Piperacillin Curasan,Piperacillin Fresenius,Piperacillin Hexal,Piperacillin Monosodium Salt,Piperacillin Sodium,Piperacillin-Ratiopharm,Pipercillin,Pipracil,Pipril,T-1220,T1220,AB Piperacillin,Cl 227193,Cl227193,Curasan, Piperacillin,Monosodium Salt, Piperacillin,Pipera Hameln,Piperacillin Ratiopharm,Salt, Piperacillin Monosodium,Sodium, Piperacillin,T 1220
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001322 Autoanalysis Method of analyzing chemicals using automation. Autoanalyses

Related Publications

M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
July 1981, American journal of clinical pathology,
M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
October 1980, Journal of clinical microbiology,
M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
August 1982, European journal of clinical microbiology,
M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
September 1980, Journal of clinical microbiology,
M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
April 1985, European journal of clinical microbiology,
M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
April 1982, Antimicrobial agents and chemotherapy,
M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
February 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
March 1986, Diagnostic microbiology and infectious disease,
M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
June 2000, Journal of clinical microbiology,
M T Mascellino, and G Prignano, and A Lorenzi, and F Iegri, and S Catania, and O Lancia, and F Sorice
March 1983, Journal of clinical microbiology,
Copied contents to your clipboard!